scholarly journals Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients

Medicine ◽  
2015 ◽  
Vol 94 (32) ◽  
pp. e1321 ◽  
Author(s):  
Liang-Tsai Hsiao ◽  
Tzeon-Jye Chiou ◽  
Jyh-Pyng Gau ◽  
Ching-Fen Yang ◽  
Yuan-Bin Yu ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Hodgkin Lymphoma ◽  
Surface Antigen ◽  
Virus Surface ◽  
Virus Surface Antigen ◽  
Non Hodgkin Lymphoma ◽  
B Virus

Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice

1997 ◽  
Vol 26 (1) ◽  
pp. 131-137 ◽  
Author(s):  
S.M. Fazle Akbar ◽  
Kazunori Kajino ◽  
Kenji Tanimoto ◽  
Kiyotaka Kurose ◽  
Toshikazu Masumoto ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Transgenic Mice ◽  
Surface Antigen ◽  
Controlled Trial ◽  
Virus Surface ◽  
Virus Surface Antigen ◽  
B Virus

New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen

2016 ◽  
Vol 211 ◽  
pp. 209-221 ◽  
Author(s):  
Indre Kucinskaite-Kodze ◽  
Milda Pleckaityte ◽  
Corinna M. Bremer ◽  
Pia L. Seiz ◽  
Milda Zilnyte ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Surface Antigen ◽  
Neutralizing Antibodies ◽  
Virus Surface ◽  
Virus Surface Antigen ◽  
B Virus
Sign in / Sign up

Export Citation Format

Share Document